$12.88
-0.28-2.13%
最終更新: Oct 26, 3:28 PM
Benzinga
Benzinga
Benzinga
月曜日, 10 26
Benzinga
© 2026 Benzinga | All Rights Reserved
Alpha Tau Medical (DRTS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.12 | $-0.13 | $-0.12 |
| Actual | $-0.50 | $-0.26 | $-0.14 | $-0.14 |
| Surprise | -257.1% | -116.7% | -7.69% | -16.7% |
| Revenue | ||||
| Estimate | $230136 | $113600 | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.15 | $-0.15 | $-0.15 | $-0.15 |
| Revenue | ||||
| Consensus | $353464 | $663600 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.50 | $-0.14 | -257.1 % |
| Q1 | May 18, 2026 | $-0.26 | $-0.12 | -116.7 % |
| Q4 | Mar 9, 2026 | $-0.14 | $-0.13 | -7.69 % |
| Q3 | Nov 20, 2025 | $-0.14 | $-0.12 | -16.7 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $0 | $230.14K | -100.0 % |
| Q1 | May 18, 2026 | $0 | $113.60K | -100.0 % |
| Q2 | Aug 14, 2024 | $0 | $30.00K | -100.0 % |